CA2077352A1 - Compositions immunogenes - Google Patents

Compositions immunogenes

Info

Publication number
CA2077352A1
CA2077352A1 CA 2077352 CA2077352A CA2077352A1 CA 2077352 A1 CA2077352 A1 CA 2077352A1 CA 2077352 CA2077352 CA 2077352 CA 2077352 A CA2077352 A CA 2077352A CA 2077352 A1 CA2077352 A1 CA 2077352A1
Authority
CA
Canada
Prior art keywords
epitope
composition
layer
response
bearing moiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2077352
Other languages
English (en)
Inventor
Uwe B. Sleytr
Wolfgang Mundt
Paul Messner
Richard H. Smith
Frank M. Unger
Andrew J. Malcolm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Alberta Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/487,729 external-priority patent/US5043158A/en
Application filed by Alberta Research Council filed Critical Alberta Research Council
Publication of CA2077352A1 publication Critical patent/CA2077352A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CA 2077352 1990-03-02 1991-03-04 Compositions immunogenes Abandoned CA2077352A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/487,729 1990-03-02
US07/487,729 US5043158A (en) 1987-08-21 1990-03-02 Immunogenic compositions containing ordered carriers

Publications (1)

Publication Number Publication Date
CA2077352A1 true CA2077352A1 (fr) 1991-09-03

Family

ID=23936884

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2077352 Abandoned CA2077352A1 (fr) 1990-03-02 1991-03-04 Compositions immunogenes

Country Status (5)

Country Link
EP (1) EP0517743A1 (fr)
JP (1) JPH05505181A (fr)
AU (1) AU7249491A (fr)
CA (1) CA2077352A1 (fr)
WO (1) WO1991012819A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9400650D0 (en) * 1994-01-14 1994-03-09 Smithkline Beecham Biolog Expression of surface lazer proteins
JP2008523116A (ja) * 2004-12-14 2008-07-03 アルカベロ アクチェセルスカプ 異種タンパク質化合物をディスプレイするバクテリア細胞を含んでなる医薬組成物
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3727987A1 (de) * 1987-08-21 1989-03-02 Sleytr Uwe B Pharmazeutische struktur

Also Published As

Publication number Publication date
EP0517743A1 (fr) 1992-12-16
WO1991012819A1 (fr) 1991-09-05
AU7249491A (en) 1991-09-18
JPH05505181A (ja) 1993-08-05

Similar Documents

Publication Publication Date Title
US5043158A (en) Immunogenic compositions containing ordered carriers
EP0399001B1 (fr) Epitopes de cellules t a titre de molecules porteuses pour vaccins conjugues
KR100290632B1 (ko) 면역성이약한항원공액체와이를포함하는합성펩티드담체와백신
AU634154B2 (en) Decoupled fiber optic feedthrough assembly
EP0180564B1 (fr) Complexe immunogénique, procédé de préparation et son utilisation comme immunostimulant, vaccins et réactifs
US5425946A (en) Vaccines against group C Neisseria meningitidis
US6177085B1 (en) Generation of immune response using immunogenic conjugate of molecules
US5773007A (en) Vaccine compositions
US4950480A (en) Enhancement of antigen immunogenicity
US5837264A (en) Potentiation of immunogenic response
EP0658118A1 (fr) Vaccins contre la neisseria meningitidis du groupe c
EP1124576B1 (fr) Preparation de vaccins conjugues en phase solide
AU684369B2 (en) Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
AU8759791A (en) Liposomes that provide thymic dependent help to weak vaccine antigens
Lett et al. Immunogenicity of polysaccharides conjugated to peptides containing T-and B-cell epitopes
CA2077352A1 (fr) Compositions immunogenes
JP2000507252A (ja) 免疫性物質を産生する方法及びワクチン
Malcolm et al. Crystalline bacterial cell surface layers (S-layers) as combined carrier/adjuvants for conjugate vaccines
Kihlberg et al. Use of carbohydrates and peptides in studies of adhesion of pathogenic bacteria and in efforts to generate carbohydrate-specific T cells
EP0895537B1 (fr) Fragment de protease iga1 en tant que peptide vehicule
Fattom Qualitative and quantitative immune response to bacterial capsular polysaccharides and their conjugates in mouse and man
CA1327523C (fr) Immunogenicite d'antigenes

Legal Events

Date Code Title Description
FZDE Dead